NASDAQ:HYPR Hyperfine - HYPR Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.25 -0.02 (-1.58%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.23▼$1.3050-Day Range$0.85▼$1.8852-Week Range$0.68▼$4.10Volume90,515 shsAverage Volume1.48 million shsMarket Capitalization$87.87 millionP/E RatioN/ADividend YieldN/APrice Target$3.97 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Hyperfine MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside218.6% Upside$3.97 Price TargetShort InterestBearish5.20% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.81Based on 19 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.02 out of 5 starsMedical Sector686th out of 995 stocksElectromedical Equipment Industry14th out of 24 stocks 3.3 Analyst's Opinion Consensus RatingHyperfine has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.97, Hyperfine has a forecasted upside of 218.6% from its current price of $1.25.Amount of Analyst CoverageHyperfine has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.20% of the float of Hyperfine has been sold short.Short Interest Ratio / Days to CoverHyperfine has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldHyperfine does not currently pay a dividend.Dividend GrowthHyperfine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HYPR. Previous Next 3.2 News and Social Media Coverage News SentimentHyperfine has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 19 news articles for Hyperfine this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for HYPR on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.MarketBeat Follows6 people have added Hyperfine to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hyperfine insiders have not sold or bought any company stock.Percentage Held by Insiders26.11% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.65% of the stock of Hyperfine is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperfine is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperfine is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperfine has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Hyperfine (NASDAQ:HYPR) StockHyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings. Hyperfine, Inc. was incorporated in 2014 and is based in Guilford, Connecticut.Read More Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address HYPR Stock News HeadlinesMarch 26, 2023 | americanbankingnews.comBrokers Offer Predictions for Hyperfine, Inc.'s FY2023 Earnings (NASDAQ:HYPR)March 23, 2023 | americanbankingnews.comHyperfine, Inc. (NASDAQ:HYPR) to Post Q1 2023 Earnings of ($0.16) Per Share, B. Riley ForecastsMarch 27, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 23, 2023 | americanbankingnews.comHyperfine (NASDAQ:HYPR) Price Target Cut to $2.50 by Analysts at B. RileyMarch 22, 2023 | finance.yahoo.comHyperfine, Inc. (HYPR) Interactive Stock Chart - Yahoo FinanceMarch 22, 2023 | americanbankingnews.comGuided Therapeutics (OTCMKTS:GTHP) versus Hyperfine (NASDAQ:HYPR) Head-To-Head ContrastMarch 22, 2023 | markets.businessinsider.comHyperfine (HYPR) Gets a Buy from B.Riley FinancialMarch 21, 2023 | finance.yahoo.comHyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 27, 2023 | Weiss Ratings (Ad)Banking NightmareDuring and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …March 20, 2023 | msn.comHyperfine's Earnings: A PreviewMarch 19, 2023 | americanbankingnews.comHyperfine (HYPR) to Release Quarterly Earnings on TuesdayMarch 6, 2023 | finance.yahoo.comHyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023February 28, 2023 | finance.yahoo.comHyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted ImagingFebruary 21, 2023 | finance.yahoo.comHyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR RegulationsFebruary 14, 2023 | marketwatch.comHyperfine Gets FDA Clearance for Updated Swoop Brain-Imaging SoftwareFebruary 8, 2023 | finance.yahoo.comHyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial OfficerJanuary 31, 2023 | marketwatch.comHyperfine Up 34% on Heavy Volume After Receiving PatentDecember 1, 2022 | benzinga.com187K Reasons To Be Bullish On Hyperfine StockNovember 22, 2022 | finance.yahoo.comHyperfine to Present at the 5th Annual Evercore ISI HealthCONx ConferenceNovember 12, 2022 | seekingalpha.comHyperfine, Inc. (HYPR) Q3 2022 Earnings Call TranscriptNovember 11, 2022 | finanznachrichten.deHyperfine, Inc.: Hyperfine Reports Third Quarter 2022 Financial ResultsNovember 10, 2022 | finance.yahoo.comHyperfine Reports Third Quarter 2022 Financial ResultsOctober 27, 2022 | finance.yahoo.comHyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022October 6, 2022 | finance.yahoo.comHyperfine Names Maria Sainz President and Chief Executive OfficerSeptember 25, 2022 | ca.finance.yahoo.comThe past year for Hyperfine (NASDAQ:HYPR) investors has not been profitableAugust 24, 2022 | finance.yahoo.comHyperfine to Participate in Upcoming Investor ConferencesAugust 18, 2022 | nasdaq.comShareholders in Hyperfine (NASDAQ:HYPR) have lost 85%, as stock drops 16% this past weekSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address HYPR Company Calendar Today3/27/2023Next Earnings (Estimated)5/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HYPR CUSIPN/A CIK1833769 Webhyperfine.io Phone866-796-6767FaxN/AEmployees186Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.97 High Stock Price Forecast$7.00 Low Stock Price Forecast$2.40 Forecasted Upside/Downside+218.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-64,850,000.00 Net Margins-1,073.73% Pretax Margin-1,073.73% Return on Equity-50.83% Return on Assets-46.98% Debt Debt-to-Equity RatioN/A Current Ratio14.62 Quick Ratio11.21 Sales & Book Value Annual Sales$6.81 million Price / Sales12.90 Cash FlowN/A Price / Cash FlowN/A Book Value$2.65 per share Price / Book0.47Miscellaneous Outstanding Shares70,580,000Free Float52,149,000Market Cap$87.87 million OptionableNot Optionable Beta0.32 Key ExecutivesMr. R. Scott Huennekens CPA (Age 58)M.B.A., Exec. Chairman Comp: $83.04kMs. Maria Sainz (Age 56)CEO, Pres & Director Comp: $1.78kDr. Jonathan M. Rothberg Ph.D. (Age 58)Founder & Vice Chairman Comp: $1.37kMr. Mark A. Hughes (Age 59)VP of Hardware Engineering & Operations Comp: $366.67kDr. Khan M. Siddiqui M.D. (Age 49)Chief Medical Officer & Chief Strategy Officer Comp: $475.25kMr. Alok Gupta (Age 56)Chief Financial Officer Ms. Kyla Pavlina J.D.Chief People OfficerMr. Scott A. White (Age 48)Chief Commercial Officer Mr. Tom TeisseyreChief Product OfficerMore ExecutivesKey CompetitorsFONARNASDAQ:FONRElectromedNYSE:ELMDBioSig TechnologiesNASDAQ:BSGMMovanoNASDAQ:MOVEAxoGenNASDAQ:AXGNView All CompetitorsInsiders & InstitutionsHealthCor Management L.P.Bought 1,131,500 shares on 2/16/2023Ownership: 5.499%Jefferies Financial Group Inc.Bought 300,000 shares on 2/15/2023Ownership: 0.425%Caz Investments LPBought 47,700 shares on 2/14/2023Ownership: 0.068%Susquehanna International Group LLPBought 12,743 shares on 2/14/2023Ownership: 0.044%Security Benefit Life Insurance Co. KSSold 34,446 shares on 2/13/2023Ownership: 3.493%View All Insider TransactionsView All Institutional Transactions HYPR Stock - Frequently Asked Questions Should I buy or sell Hyperfine stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HYPR shares. View HYPR analyst ratings or view top-rated stocks. What is Hyperfine's stock price forecast for 2023? 3 brokerages have issued 1-year target prices for Hyperfine's shares. Their HYPR share price forecasts range from $2.40 to $7.00. On average, they expect the company's share price to reach $3.97 in the next year. This suggests a possible upside of 218.6% from the stock's current price. View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts. How have HYPR shares performed in 2023? Hyperfine's stock was trading at $0.84 at the start of the year. Since then, HYPR stock has increased by 48.2% and is now trading at $1.2450. View the best growth stocks for 2023 here. When is Hyperfine's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023. View our HYPR earnings forecast. What guidance has Hyperfine issued on next quarter's earnings? Hyperfine issued an update on its FY 2023 earnings guidance on Wednesday, March, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $10.00 million-$14.00 million, compared to the consensus revenue estimate of $14.65 million. What is Hyperfine's stock symbol? Hyperfine trades on the NASDAQ under the ticker symbol "HYPR." Who are Hyperfine's major shareholders? Hyperfine's stock is owned by many different institutional and retail investors. Top institutional investors include HealthCor Management L.P. (5.50%), Security Benefit Life Insurance Co. KS (3.49%), Wells Fargo & Company MN (0.54%), Jefferies Financial Group Inc. (0.43%), Caz Investments LP (0.07%) and Susquehanna International Group LLP (0.04%). Insiders that own company stock include Alok Gupta, Hc Sponsor Llc, Jonathan M Rothberg, Khan Siddiqui, Maria Sainz and Neela Paykel. View institutional ownership trends. How do I buy shares of Hyperfine? Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Hyperfine's stock price today? One share of HYPR stock can currently be purchased for approximately $1.25. How much money does Hyperfine make? Hyperfine (NASDAQ:HYPR) has a market capitalization of $87.87 million and generates $6.81 million in revenue each year. The company earns $-64,850,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis. How many employees does Hyperfine have? The company employs 186 workers across the globe. How can I contact Hyperfine? Hyperfine's mailing address is 55 HUDSON YARDS 28TH FLOOR, NEW YORK NY, 10001. The official website for the company is hyperfine.io. The company can be reached via phone at 866-796-6767 or via email at investors@hyperfine.io. This page (NASDAQ:HYPR) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.